October 3, 2006
Bayer's Tardy Report to FDA
Posted at October 3, 2006 7:49 AM in Drug Products
.
Bayer AG has failed to disclose to regulators potentially serious safety concerns about its antibleeding drug Trasylol. The FDA has disclosed that preliminary test results indicate that the drug may cause serious kidney damage, congestive heart failure and strokes and an increased risk of death.
Trackback
You can ping this entry by using http://www.saundersblog.com/cgi-bin/mt/mt-tb.cgi/337 .